ARCHIVES

Preoperative Drug Combo Benefits HER-2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

No Controversy Over Cancer Act This Time

May 25, 1990

President’s Budget Would Permit NCI Funding Of Only 23.2% Of Approved Traditional Grants

January 26, 1979

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977